LDA analysis for Study ST003432

(Analysis AN005637 )

Select 3 or more experimental factors for PCA analysis.
GroupExperimental factor
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:0.1 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:100 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:20 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:50 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:Control
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:0.1 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:100 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:1 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:20 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:50 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:5 uM LW6
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:Control
Sample source:NA | Sample Type:Blank | Drug Treatment:NA
Sample source:NA | Sample Type:Medium | Drug Treatment:Control
Sample source:NA | Sample Type:QC | Drug Treatment:NA

OR

Perform LDA on individual factors (all analyses in study)
  logo